Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1969 3
1970 7
1971 3
1972 3
1973 3
1974 17
1975 9
1976 5
1977 13
1978 18
1979 16
1980 26
1981 23
1982 34
1983 45
1984 33
1985 24
1986 45
1987 34
1988 39
1989 38
1990 41
1991 50
1992 49
1993 36
1994 37
1995 37
1996 55
1997 56
1998 49
1999 61
2000 63
2001 67
2002 65
2003 62
2004 51
2005 66
2006 66
2007 70
2008 74
2009 75
2010 61
2011 73
2012 82
2013 70
2014 76
2015 78
2016 82
2017 76
2018 77
2019 87
2020 106
2021 116
2022 90
2023 80
2024 87

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,618 results

Results by year

Filters applied: . Clear all
Page 1
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD).
Corte TJ, Lancaster L, Swigris JJ, Maher TM, Goldin JG, Palmer SM, Suda T, Ogura T, Minnich A, Zhan X, Tirucherai GS, Elpers B, Xiao H, Watanabe H, Smith RA, Charles ED, Fischer A. Corte TJ, et al. Among authors: suda t. BMJ Open Respir Res. 2021 Dec;8(1):e001026. doi: 10.1136/bmjresp-2021-001026. BMJ Open Respir Res. 2021. PMID: 34969771 Free PMC article. Clinical Trial.
SDHAF1 confers metabolic resilience to aging hematopoietic stem cells by promoting mitochondrial ATP production.
Watanuki S, Kobayashi H, Sugiura Y, Yamamoto M, Karigane D, Shiroshita K, Sorimachi Y, Morikawa T, Fujita S, Shide K, Haraguchi M, Tamaki S, Mikawa T, Kondoh H, Nakano H, Sumiyama K, Nagamatsu G, Goda N, Okamoto S, Nakamura-Ishizu A, Shimoda K, Suematsu M, Suda T, Takubo K. Watanuki S, et al. Among authors: suda t. Cell Stem Cell. 2024 Aug 1;31(8):1145-1161.e15. doi: 10.1016/j.stem.2024.04.023. Epub 2024 May 20. Cell Stem Cell. 2024. PMID: 38772377
MBTD1 preserves adult hematopoietic stem cell pool size and function.
Takubo K, Htun PW, Ueda T, Sera Y, Iwasaki M, Koizumi M, Shiroshita K, Kobayashi H, Haraguchi M, Watanuki S, Honda ZI, Yamasaki N, Nakamura-Ishizu A, Arai F, Motoyama N, Hatta T, Natsume T, Suda T, Honda H. Takubo K, et al. Among authors: suda t. Proc Natl Acad Sci U S A. 2023 Aug 8;120(32):e2206860120. doi: 10.1073/pnas.2206860120. Epub 2023 Jul 31. Proc Natl Acad Sci U S A. 2023. PMID: 37523546 Free PMC article.
Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.
Jikuya R, Johnson TA, Maejima K, An J, Ju YS, Lee H, Ha K, Song W, Kim Y, Okawa Y, Sasagawa S, Kanazashi Y, Fujita M, Imoto S, Mitome T, Ohtake S, Noguchi G, Kawaura S, Iribe Y, Aomori K, Tatenuma T, Komeya M, Ito H, Ito Y, Muraoka K, Furuya M, Kato I, Fujii S, Hamanoue H, Tamura T, Baba M, Suda T, Kodama T, Makiyama K, Yao M, Shuch BM, Ricketts CJ, Schmidt LS, Linehan WM, Nakagawa H, Hasumi H. Jikuya R, et al. Among authors: suda t. EBioMedicine. 2023 Jun;92:104596. doi: 10.1016/j.ebiom.2023.104596. Epub 2023 May 12. EBioMedicine. 2023. PMID: 37182269 Free PMC article.
[Ageing of hematopoietic stem cells].
Shiozaki H, Nakamura-Ishizu A, Suda T. Shiozaki H, et al. Among authors: suda t. Rinsho Ketsueki. 2018;59(1):3-12. doi: 10.11406/rinketsu.59.3. Rinsho Ketsueki. 2018. PMID: 29415934 Review. Japanese.
2,618 results